Busulfan neurotoxicity and EEG abnormalities: A case report

Neurological Sciences

Volumn 25, Issue 2, 2004, Pages 95-97

  La Morgia, Chiara ^a   Mondini, S ^a   Guarino, M ^a   Bonifazi, F ^b   Cirignotta, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone marrow transplantation; Busulfan; EEG; Seizures

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAUNORUBICIN; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE; PHENOBARBITAL; PREDNISONE; VALPROIC ACID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CONVALESCENCE; DELTA RHYTHM; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEUROTOXICITY; SLOW BRAIN WAVE; SPIKE; THETA RHYTHM; TONIC CLONIC SEIZURE;

EID: 3142717604     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-004-0237-0     Document Type: Article

References (13)

1. DeMagalhaes-Silverman M, Bloom EJ, Donnenberg A, Lister J, Pincus S, Rybka WB, Ball ED (1996) Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with haematologic malignancies. Bone Marrow Transplantation 17:329-333
2. Antonini G, Ceschin V, Morino S, Fiorelli M, Gragnani F, Mengarelli A, Iori AP, Arcese W (1998) Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 50:1441-1445
3. Kobayashi R, Watanabe N, Iguchi A, Cho Y, Yoshida M, Arioka H, Naito H, Shikano T, Ishikawa Y (1998) Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation. Bone Marrow Transplantation 21:217-220
4. Meloni G, Raucci U, Pinto RM, Spalice A, Vignetti M, Iannetti P (1992) Pretransplant conditioning with busulfan and cyclophosphamide in acute leukemia patients: neurological and electroencephalographic prospective study. Ann Oncol 3:145-148
5. Murphy CP, Harden EA, Thompson JM (1992) Generalized seizures secondary to high-dose busulfan therapy. Ann Pharmacother 26(1):30-31
6. De La Camara R, Tomas JF, Figuera A, Berberana M, Fernandez-Ranãda JM (1991) High dose busulfan and seizures. Bone Marrow Transplantation 7:363-364
7. Andersson BS, Kashyap A, Gian V, Wingard JR, Fernandez H, Cagnoni PJ, Jones RB, Tarantolo S, Hu WW, Blume KG, Forman SJ, Champlin RE (2002) Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study. Biol Blood Marrow Transplantation 8:145-154
8. Vassal G, Deroussent A, Hartmann O, Challine D, Benhamou E, Valteau-Couanet D, Brugieres L, Kalifa C, Gouyette A, Lemerle J (1990) Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res 50:6203-6207
9. Martell RW, Sher C, Jacobs P, Monteagudo F (1987) High-dose busulfan and myoclonic epilepsy. Ann Intern Med 106:173
10. Marcus RE, Goldman JM (1984) Convulsions due to high-dose busulphan. Lancet 2:1463
11. Grigg AP, Shepherd JD, Phillips GL (1989) Busulphan and Phenytoin. Ann Intern Med 111:1049-1050
12. Hassan M, Oberg G, Bjorkholm M, Wallin I, Lindgren M (1993) Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. Cancer Chemother Pharmacol 33(3):181-186
13. Chan KW, Mullen CA, Worth LL, Choroszy M, Koontz S, Tran H, Slopis J (2002) Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplantation 29(12):963-965